![]() Akero Therapeutics Akero Therapeutics develops medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. | ![]() OaCP OaCP (Oncology and Cytogenetic Products) is a company that provides oncology diagnostics laboratories and research institutions with FISH (fluorescence in situ hybridization) solutions. | ||
Founding Date | Founding Date 2013 | Founding Date 2017 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Seattle, US HQ Seattle, US | Locations San Francisco, US HQ Cambridge, US South San Francisco, US | Locations Cork, IE HQ |
Employees | Employees 254% increase | Employees 1363% increase | Employees 5 |
Funding | |||
Total funding raised | Total funding raised $ 2.7m | Total funding raised $ 135m | Total funding raised N/A |

Akero Therapeutics develops medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.
View company
OaCP (Oncology and Cytogenetic Products) is a company that provides oncology diagnostics laboratories and research institutions with FISH (fluorescence in situ hybridization) solutions.
View company